Evidence map›Paper›PMID 39961581›Full record

Trial reportJournal of substance use and addiction treatment2025

The difference-making role of staff support in implementing nurse care management for opioid use disorder treatment: A configurational analysis.

Theresa E Matson, Amy K Lee, Edward J Miech, Paige D Wartko, Rebecca C Phillps, Mary Shea, Andrea Altschuler, Aimee N C Campbell, Colleen T Labelle, Julia H Arnsten and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Theresa E MatsonKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA; Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA 98195, USA. Electronic address: tessa.e.matson@kp.org.
Amy K LeeKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.
Edward J MiechDepartment of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Paige D WartkoKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA; Department of Epidemiology, University of Washington, 3980 15th Ave NE, Seattle, WA 98195, USA.
Rebecca C PhillpsKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.
Mary SheaKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.
Andrea AltschulerKaiser Permanente Northern California Division of Research, Pleasanton, CA 94588, USA.
Aimee N C CampbellDepartment of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY 10032, USA.
Colleen T LabelleBoston Medical Center, Boston University Schools of Medicine and Public Health, Boston, MA 02118, USA.
Julia H ArnstenMontefiore Medical Center, Bronx, NY 10467, USA; Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Jordan M BraciszewskiCenter for Health Policy and Health Services Research, Henry Ford Health, Detroit, MI 48202, USA.
Joseph E GlassKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA; Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA 98195, USA.
Viviana E HorigianDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Mark T MurphyMultiCare Health System, Tacoma, WA 98415, USA.
Mohammad Zare-MehrjerdiDepartment of Family and Community Medicine, UTHealth Houston McGovern Medical School, Houston, TX 77030, USA.
Katharine A BradleyKaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA; Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA 98195, USA; Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA 98195, USA.

Funding

Project-003UG1DA013035 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aimee N Campbell, Jennifer McNeely · 2015 to 2026
$130.3M
The National Drug Abuse Treatment Clinical Trials NetworkUG1DA015831 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Roger D. Weiss · 2015 to 2026
$110.8M
Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Project-002UG1DA040314 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Ingrid A Binswanger, CYNTHIA I CAMPBELL · 2015 to 2026
$34.9M
CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
Transforming health equity rhetoric to rigor: Development and validation of a novel measure assessing health equity in implementation of health interventionsP50DA054072 · NIDA · STANFORD UNIVERSITY · PI Mark P McGovern · 2022 to 2026
$18.1M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
NIDA NIH HHS P50 DA054072NIDA NIH HHS T32 DA037801NIDA NIH HHS U10 DA013714NIDA NIH HHS UG1 DA013035NIDA NIH HHS UG1 DA013714NIDA NIH HHS UG1 DA013720NIDA NIH HHS UG1 DA015831NIDA NIH HHS UG1 DA020024NIDA NIH HHS UG1 DA040314
6 · The paper itself

Abstract

introductionUnderstanding conditions in which interventions succeed or fail is critical. The PRimary care Opioid Use Disorders treatment (PROUD) trial, a cluster-randomized hybrid study, tested whether implementation of office-based addiction treatment supported by a nurse increased medication of OUD. Six health systems each provided two primary care (PC) clinics that were randomly assigned to implement the intervention or usual care. This secondary, exploratory study used an innovative mixed methods approach to understand contextual factors that consistently distinguished intervention clinics that increased OUD treatment from those that did not.

methodsThe study collected contextual information through field notes, health system debriefs, and nurse interviews. Rapid qualitative analysis using a template based on the Practical, Robust Implementation and Sustainability Model identified themes reflecting the external environment, recipients, and implementation infrastructure. The study used qualitative themes to create binary factors reflecting barriers and facilitators potentially critical to implementation success and assigned clinics a factor value of 1 if present and 0 if absent. Two clinic-level outcomes were defined: 1) significant increase in patient-years of OUD treatment from baseline to two-year follow-up; and 2) high rate of OUD treatment at two-year follow-up (≥20 per 10,000 patient-years). Coincidence analysis, a cross-case configurational method, identified difference-makers for both OUD outcomes across intervention clinics.

resultsQualitative analysis yielded 11 themes which were dichotomized and consolidated into 9 factors. Two factor values perfectly distinguished between intervention clinics with and without increased OUD treatment (outcome #1): (a) presence of strong support from PC staff and providers and (b) lack of OUD treatment in the community. Intervention clinics increased OUD treatment when either factor value was present; when both were absent, clinics did not increase treatment. Strong support from PC staff and providers was independently sufficient to achieve high rates of OUD treatment (outcome #2) while the absence of support explained low rates of treatment. Importantly, strong support from leadership was not sufficient for either outcome.

conclusionStrong support from staff and providers consistently differentiated between clinics with increased OUD treatment across both outcomes in the PROUD trial from those without. OUD programs should consider increasing support across clinic roles.

Indexed as

Opiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareAdultFemaleHumansMaleMiddle AgedCoincidence analysisConfigurational methodsImplementationMedication assisted treatmentMixed methodOpioid use disorder

Identifiers

PMID39961581
PMCPMC12009210

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.